Broadening Narsoplimab Development from Orphan Indication to COVID-19 Treatment: CMC Regulatory Considerations
Speaker Presentation Harris Jonathan, Omeros Corporation, 2021
Broadening Narsoplimab Development from Orphan Indication to COVID-19 Treatment: CMC Regulatory Considerations